ULBP1 and glioblastoma: Thus, it will be important in future studies to use flow cytometry or immunohistochemistry with antibodies to ULBP1 to analyze the brains of mice bearing different GBM PDXs that are treated with vehicle, single agents, or TMZ and niraparib via oral gavage and sacrificed at increasing amounts of time post-treatment.